Most Active Stories
- The San Francisco Opera: Giuseppe Verdi’s Rigoletto
- Concealed carry gun instructor: There are extremists on both sides of gun debate
- Live in Alexandria! Fred Child, Host of Performance Today
- Aspen Ideas Festival 2015: Sen. Lindsey Graham on values worth fighting for.
- Health Matters: Pregnancy and post-delivery issues.
Novartis Loses Patent Battle In India
Originally published on Fri April 5, 2013 7:50 am
STEVE INSKEEP, HOST:
NPR's business news starts with a patent ruling that may affect millions.
(SOUNDBITE OF MUSIC)
INSKEEP: The ruling comes from the supreme court of India, a country with a population somewhere north of a billion. The Indian supreme court rejected patent rights claimed by the pharmaceutical giant Novartis. This ruling opens the door for Indian drug makers to produce generic versions of Novartis' lifesaving cancer drugs and will make the medicine more affordable for people in developing nations. Transcript provided by NPR, Copyright NPR.